Form 4: Ingredion Inc. Executive Acquires Shares and Stock Options
SEC Form 4 Filing
Michael O'Riordan, SVP at Ingredion Inc., reports acquisition of common stock and stock options.
Summary
- On February 26, 2025, Michael O'Riordan, a Senior Vice President at Ingredion Inc., acquired 1,350 shares of common stock at a price of $130.57 per share.
- Following this transaction, O'Riordan directly owns 9,308.3915 shares of Ingredion Inc. common stock.
- O'Riordan also acquired 5,219 employee stock options with an exercise price of $130.57, exercisable in three equal annual installments starting February 26, 2026, and expiring on February 26, 2035.
- These options give O'Riordan the right to buy 5,219 shares of common stock.
- The filing also indicates that O'Riordan was granted 1,350 restricted stock units (RSUs) that will vest on February 26, 2028, and can be settled for common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by an executive suggests confidence, but it's a routine filing.
Positives
- The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules for the stock options and RSUs extend into 2028 and 2035, suggesting a long-term commitment from the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and terms of these grants are generally consistent with industry practices.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company executive.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of transaction: Acquisition of common stock and stock options. |
| 02/26/2026 | First vesting date for employee stock options. |
| 02/26/2027 | Second vesting date for employee stock options. |
| 02/26/2028 | Third vesting date for employee stock options and vesting date for RSUs. |
| 02/26/2035 | Expiration date for employee stock options. |
| 02/28/2025 | Date of signature by attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.